COA
Certificate of Analysis
Third-party HPLC and MS testing for every batch, published before purchase and tied to the batch being sold.
HPLC / MS
Endocrine Research
Tesamorelin10mg
Growth hormone-releasing hormone analog for endocrine-axis research.
$80per vial
Product handling note
Lyophilized powder may shift or come loose during transit; that is a normal occurrence and does not affect the integrity of the research product. Fill appearance and batch-specific details may vary. Refer to the Certificate of Analysis below for the documentation tied to the current batch.
Research overview
Why researchers study GHRH analogs.
Tesamorelin is studied as a synthetic analog of growth hormone-releasing hormone, usually shortened to GHRH. The research frame is endocrine-axis signaling: how a GHRH-style ligand engages the pituitary pathway and how downstream GH and IGF-1 signals can be modeled.
The useful comparison is not a consumer outcome claim. It is a receptor-and-axis question: how GHRH analog structure, stability, GH pulse behavior, and IGF-1 response are documented in controlled research contexts.
The receipts
What you get with every vial.
ID
Batch traceability
Every vial is stamped with a batch ID that links back to its COA, source record, and current product documentation.
Batch linkedLabel
Batch-linked labeling
Product identity, strength, and batch reference stay easy to match from the product listing to the vial in hand.
Listing to vialRelated peptides
Adjacent research lanes.
Product FAQ
Common research questions.
What does GHRH mean?
GHRH stands for growth hormone-releasing hormone. It is the endocrine signaling lane researchers use when studying how pituitary GH release is regulated.
Why does Tesamorelin get discussed with IGF-1?
Published tesamorelin research often tracks GH-axis activity through downstream IGF-1 response. IGF-1 is a common readout because GH signaling can influence hepatic IGF-1 production.
How is this different from HCG research?
HCG sits in the LHCGR endocrine lane. Tesamorelin sits in the GHRH / GH-axis lane, so the receptor context and downstream readouts are different even though both belong in endocrine research.
What should the batch documentation clarify?
It should clarify identity, purity, labeled strength, measured strength where available, and the exact batch code on the vial. For this product, that means the page should connect VR-TSM-2026-001 to its release record.
Research sources
Literature links are included for background reading. Batch-specific identity and purity details live in the COA tied to the current batch.